Search

Your search keyword '"Rouwendal, Gerard"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Rouwendal, Gerard" Remove constraint Author: "Rouwendal, Gerard"
36 results on '"Rouwendal, Gerard"'

Search Results

1. Abstract 2934: BYON4228, an antagonistic SIRPα mAb with a unique and favorable preclinical profile compared to three comparator SIRPα mAbs

2. Suppl fig 1 from Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing

3. Suppl fig 5 from Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing

4. Suppl fig 4 from Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing

5. Suppl fig 3 from Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing

6. Suppl fig 2 from Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing

7. Data from Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing

8. Supplementary data from Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing

9. BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells

10. 495 BYON4228, a pan-allelic SIRPα blocking antibody with a favorable pre-clinical safety profile, enhances anti-tumor immunity in vitro and in vivo

11. Abstract 5589: BYON4228 is a pan-allelic SIRPα antibody that potentiates killing of antibody-opsonized tumor cells and lacks binding to T cells

16. Identification of the gene encoding the [alpha]1,3-mannosyltransferase (ALG3) in Arabidopsis and characterization of downstream N-glycan processing

17. An antibody produced in tobacco expressing a hybrid [beta]-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes

23. Genomic and biochemical analysis of N glycosylation in the mushroom-forming basidiomycete Schizophyllum commune

24. Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing

25. Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting

26. A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA

32. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III

36. Ligase Chain Reaction for Site-Directed In Vitro Mutagenesis.

Catalog

Books, media, physical & digital resources